MirZyme
MIRZYME AWARDED THE FIRST FAST-TRACK INNOVATION PASSPORT FOR THE TREATMENT OF PREECLAMPSIA
MIRZYME THERAPEUTICS AWARDED THE FIRST FAST-TRACK INNOVATION PASSPORT FOR THE TREATMENT OF PREECLAMPSIA FROM THE MHRA, THE UK REGULATOR...
top of page
INvestor
Investors
MirZyme has zero debt and is financed by equity. The company intends to progress each of its pipeline of patented products in a way that those that will generate income in the shorter term can finance the development of those that will take longer to bring to market.
News and Media
MirZyme
- Sep 26, 2022
CEO Nominated for Businessman of The Year
CEO of Mirzyme Professor Asif Ahmed (www.asifahmed.org) has been nominated for Birmingham Buisnessman Of The Year 2022. He is a...
MirZyme
- Sep 26, 2022
Women’s Health Innovation Summit - Boston, USA
Mirzyme has been selected as a finalist for the Women's Health Innovation Showcase USA. Out of 125 companies, Mirzyme is one of 24 to be...
MirZyme
- May 20, 2022
U.K. policy report sets out a vision to incentivise industry to develop pregnancy-specific medicines
The United Kingdom published its first policy commission report on maternal drug development. The report was launched in the House of...
MirZyme
- May 14, 2022
ONE PILL WONDER – MirZyme Therapeutics on AIMDay at Oxford University
The Nuffield Department of Women’s & Reproductive Health at the University of Oxford hosted an Academic-Industry Meeting Day (AIMday) in...
MirZyme
- Jun 25, 2021
Women's Health Strategy: Call for Evidence
The UK government asked the views of organisations, experts and individuals to help inform the development of the government’s Women’s...
MirZyme
- Jun 8, 2021
COVID-19 leads to preeclampsia and poor pregnancy outcomes
Birmingham, June 2021 A peer-reviewed article in the prestigious British Journal of Pharmacology “The Impact of COVID-19 on Pregnancy and...
MirZyme
- May 11, 2021
Saving the Lives of Mothers and Babies - Webinar
The month of May is Preeclampsia Awareness Month. Through a series of webinars, discussions and workshops, MirZyme is raising awareness...
MirZyme
- Dec 16, 2020
Two breakthrough studies show a hydrogen sulfide drug prevents preeclampsia
Preeclampsia is a life-threatening pregnancy disorder affecting one in twelve of 130 million annual pregnancies worldwide and causes the...
MirZyme
- Nov 16, 2020
MirZyme Therapeutics partners with King Abdulaziz University
MirZyme Therapeutics partners with King Abdulaziz University to accelerate the development of targeted therapeutics using artificial...
MirZyme
- Oct 24, 2020
Scientists at MirZyme have developed a breakthrough ‘miracle’ cure for preeclampsia
PRESS RELEASE Scientists at MirZyme Therapeutics have discovered a cure for preeclampsia, a life- threatening hypertensive disorder...
MirZyme
- Jan 15, 2019
Europe’s New Roadmap for a Healthier Pregnancy
The death of Lady Sybil during childbirth in the BBC period drama ‘Downton Abbey’ highlighted the risky business of pregnancy caused by...
MirZyme
- Aug 9, 2015
The statin that saves babies from stillbirth
Discovery could save pregnant women from potentially fatal high blood pressure condition. A statin used to lower cholesterol could also...
MirZyme
- May 28, 2013
Breakthrough in fight against pre-eclampsia: Scientists may have found cause of the life-threatening
Scientists may have found the cause of the life-threatening pregnancy condition pre-eclampsia – using a gas that smells like rotten eggs....
Publications
Publications
bottom of page